These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24722314)

  • 1. The thalamus: a small but precious window on τ-related neurodegeneration?
    Filippi M; Agosta F; Caso F
    AJNR Am J Neuroradiol; 2014 May; 35(5):904-5. PubMed ID: 24722314
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging.
    Hess CP; Christine CW; Apple AC; Dillon WP; Aminoff MJ
    AJNR Am J Neuroradiol; 2014 May; 35(5):897-903. PubMed ID: 24356677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
    Surova Y; Nilsson M; Lätt J; Lampinen B; Lindberg O; Hall S; Widner H; Nilsson C; van Westen D; Hansson O
    Neuroradiology; 2015 Nov; 57(11):1079-91. PubMed ID: 26253801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.
    Boelmans K; Holst B; Hackius M; Finsterbusch J; Gerloff C; Fiehler J; Münchau A
    Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy.
    Kepe V; Bordelon Y; Boxer A; Huang SC; Liu J; Thiede FC; Mazziotta JC; Mendez MF; Donoghue N; Small GW; Barrio JR
    J Alzheimers Dis; 2013; 36(1):145-53. PubMed ID: 23579330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with progressive supranuclear palsy.
    Kamiya K; Sato N; Ota M; Nakata Y; Ito K; Kimura Y; Murata M; Mori H; Kunimatsu A; Ohtomo K
    J Neuroradiol; 2013 May; 40(2):121-9. PubMed ID: 23428241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic extraction of the cingulum bundle in diffusion tensor tract-specific analysis: feasibility study in Parkinson's disease with and without dementia.
    Ito K; Masutani Y; Kamagata K; Yasmin H; Suzuki Y; Ino K; Aoki S; Kunimatsu A; Ohtomo K
    Magn Reson Med Sci; 2013; 12(3):201-13. PubMed ID: 23857147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits.
    Li C; Takahashi T; Shrestha T; Kinoshita E; Matsubara T; Matsumoto M; Maruyama H
    J Histochem Cytochem; 2018 Oct; 66(10):737-751. PubMed ID: 30106598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy.
    Hanyu H; Asano T; Sakurai H; Takasaki M; Shindo H; Abe K
    Neuroradiology; 2001 Jul; 43(7):542-6. PubMed ID: 11512582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.